tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 78 are a BUY (86.67%), 12 are a HOLD (13.33%).
Analyst Scott Henry, currently employed carries an average stock price target met ratio of 53.91% that have a potential upside of 39.85% achieved within 152 days. Previously, Scott Henry worked at ROTH.
Scott Henry’s has documented 178 price targets and ratings displayed on 29 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on DERM, Journey Medical Corp at 16-Feb-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS ORPORATED) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $8.54 (7.35%) receiving and performance score of 73.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$94
$35.81 (61.54%)
$94
1 months 19 days ago
(17-Sep-2024)
4/10 (40%)
$33.94 (56.51%)
148
Buy
$77
$18.81 (32.33%)
$72
6 months 13 days ago
(23-Apr-2024)
3/7 (42.86%)
$10.86 (16.42%)
89
Buy
$80
$21.81 (37.48%)
$72
8 months 4 days ago
(01-Mar-2024)
2/7 (28.57%)
$12.83 (19.10%)
31
Buy
$49
$-9.19 (-15.79%)
$48
1 years 5 months 27 days ago
(09-May-2023)
10/11 (90.91%)
$4.59 (10.34%)
474
Hold
$42
$-16.19 (-27.82%)
$40
1 years 5 months 28 days ago
(08-May-2023)
2/3 (66.67%)
$-0.58 (-1.36%)
274
What Year was the first public recommendation made by Scott Henry?
